Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
KdT Ventures
AddedFeb 13, 2024
UpdatedJul 16, 2026
KdT Ventures

KdT Ventures

Operating

KdT Ventures: A seed-stage venture firm, transforming ideas into impactful tech-science companies.

Location
Austin, TX, US
Founded
2017
Firm
Compare
Portfolio
Fundraising
Employees
Website

KdT Ventures is a seed-stage venture capital firm that specializes in investing at the intersection of technology and science. They focus on early-stage companies, often being the first to invest, with a unique model that aims to have a significant impact on the earliest stages of a venture. Their investment philosophy centers on re-architecting the world at a molecular level, addressing the physical layer that has remained largely unchanged despite advancements in computation.

Notable portfolio companies include 54Gene, Asimov, Dyno Therapeutics, and PathAI, which have collectively raised substantial funding. KdT Ventures is led by key partners who bring extensive experience and networks to the table, offering unique value-add services to their portfolio companies. These services include strategic guidance, operational support, and access to a broad network of industry experts and potential collaborators, helping startups navigate their growth and development phases effectively.

KdT Ventures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments56
Current Portfolio Count33
Total Portfolio Exits2

Top Investment Stages

Seed27 (48.2%)
Series A23 (41.1%)
Series B4 (7.1%)
Convertible Note1 (1.8%)
Pre-Seed1 (1.8%)

Stage Mix

Seed 48%Series A 41%Series B 7%Convertible Note 2%Pre-Seed 2%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Motif Neurotech logo

Motif Neurotech

Zymochem logo

Zymochem

Aperiam Bio logo

Aperiam Bio

Surge Therapeutics logo

Surge Therapeutics

Andes logo

Andes

Dimension Inx logo

Dimension Inx

Asimov logo

Asimov

Onc.AI logo

Onc.AI

54Gene logo

54Gene

Equii logo

Equii

Tavros Therapeutics logo

Tavros Therapeutics

Canaery logo

Canaery

Faeth Therapeutics logo

Faeth Therapeutics

Terray Therapeutics logo

Terray Therapeutics

Marigold Health logo

Marigold Health

Green Eye Technology logo

Green Eye Technology

Parthenon Therapeutics logo

Parthenon Therapeutics

Unravel Biosciences logo

Unravel Biosciences

Debut logo

Debut

Modulus Therapeutics logo

Modulus Therapeutics

Xilis logo

Xilis

Dyno Therapeutics logo

Dyno Therapeutics

Rejuvenate Bio logo

Rejuvenate Bio

SeQure Dx logo

SeQure Dx

Theator logo

Theator

KdT Ventures - Classification

Also Known As
  • KDT Ventures PTY LTD
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end